| Literature DB >> 32629103 |
Chen Su1, Depeng Fan2, Luqing Pan3, Yusong Lu1, Yuxuan Wang1, Mengyu Zhang1.
Abstract
A 28-day feeding trial was conducted to investigate the effects of Yu-Ping-Feng polysaccharides (YPS) containing Astragalus polysaccharides (APS), Atractylodes macrocephala polysaccharides (AMP) and Saposhnikoviae polysaccharides (SPS) on the immune response, intestinal microbiota, disease resistance and growth performance of Litopenaeus vannamei. Seven hundred and twenty shrimp (3.04 ± 0.33 g) were fed the following diets: Control, YPS1 (0.13% APS + 0.0325% AMP + 0.0325% SPS), YPS2 (0.13% APS + 0.0325% AMP + 0.065% SPS) and YPS3 (0.13% APS + 0.0325% AMP+0.0975% SPS). After 14 and 28 days of feeding, the immune responses of hemocytes and intestine were measured. Intestinal microbiota and growth performance were measured after 28 days of feeding, after that, a 7-day challenge test against Vibrio harveyi was conducted. A significant (P < 0.05) increase of the total haemocyte count (THC), phagocytic activity, antibacterial activity and phenoloxidase (PO) activity was observed in shrimp fed YPS diets compared to the control. Also, dietary YPS supplementation particularly YPS3 group significantly increased the expressions of immune-related genes in the hemocytes and intestine. Regarding the intestinal microbiota, the microbial diversity and richness decreased and functional genes associated with short-chain fatty acids metabolism increased in YPS groups. After Vibrio harveyi challenge, the cumulative mortality in YPS groups was significantly lower than that of the control. Besides, dietary YPS had no significant effect on growth performance of shrimp (P > 0.05). The present results suggested that YPS could be considered as potential prebiotics for aquaculture farmed shrimp.Entities:
Keywords: Immune response; Intestine microbiota; Litopenaeus vannamei; Prebiotics; Yu-Ping-Feng polysaccharides
Mesh:
Substances:
Year: 2020 PMID: 32629103 PMCID: PMC7333637 DOI: 10.1016/j.fsi.2020.07.003
Source DB: PubMed Journal: Fish Shellfish Immunol ISSN: 1050-4648 Impact factor: 4.581
Experimental diets composition and nutrition level.
| Ingredient (%) | Diets | |||
|---|---|---|---|---|
| Control | YPS1 | YPS2 | YPS3 | |
| Fish meal | 29 | 29 | 29 | 29 |
| Peanut meal | 18 | 18 | 18 | 18 |
| Soybean meal | 16 | 16 | 16 | 16 |
| Squid visceral meal | 5 | 5 | 5 | 5 |
| Wheat flour | 25.3 | 25.3 | 25.3 | 25.3 |
| Fish oil | 2.5 | 2.5 | 2.5 | 2.5 |
| Vitamin C ester (35%) | 0.1 | 0.1 | 0.1 | 0.1 |
| Ca(H2PO4)2 | 1 | 1 | 1 | 1 |
| Choline chloride (50%) | 0.25 | 0.25 | 0.25 | 0.25 |
| Soybean phospholipid | 2 | 2 | 2 | 2 |
| Cholesterol | 0.1 | 0.1 | 0.1 | 0.1 |
| Vitamin premix | 0.25 | 0.25 | 0.25 | 0.25 |
| Mineral premix | 0.5 | 0.5 | 0.5 | 0.5 |
| APS | 0 | 1.3 | 1.3 | 1.3 |
| AMP | 0 | 0.325 | 0.325 | 0.325 |
| SPS | 0 | 0.325 | 0.65 | 0.975 |
| Crude protein | 45.6 | 45.1 | 45.8 | 45.8 |
| Crude lipid | 8.3 | 8.4 | 8.3 | 8.2 |
| Ash | 11.6 | 10.8 | 11.4 | 11.2 |
| Fibre | 3.8 | 3.6 | 3.8 | 3.4 |
| Moisture | 7.1 | 7.6 | 7.5 | 7.5 |
Per kg Vitamin premix contains the following: VA 4,000,000 IU, VB1 5g, VB2 15 g, VB6 8g, VB12 40 g, VD 2,000,000 IU, VE 30 g, VK 10 g, calcium pantothenate 25 g, folic acid 2.5 g, biotin 0.08 g, nicotinic acid 30 g, inositol 150 g.
Per kg Mineral premix contains the following: MgSO4·H2O 12 g, KCl 90 g, Met-Cu 3 g, Met-Co 0.16 g, FeSO4·H2O 1 g, ZnSO4·H2O 10 g, Ca(IO3)2 0.06 g, NaSeO3 0.0035 g.
Primer sequences used in this study.
| Primer name | Primer sequences (5′–3′) | GenBank accession number | Product size (bp) |
|---|---|---|---|
| TCGACCATCCCTTTTACACC | 88bp | ||
| TTGCCTGGAAGGTCTGATTC | |||
| TCACATTGGCCCCGTTATCC | 117bp | ||
| ATCTCGCGACTGCACTTCAA | |||
| TTGCGACCACCAGACAAGAG | SRP132193 | 142bp | |
| GCAAGGTAACGACTAATCTTCTCTG | SRP132193 | ||
| CTACATTCTGCCCTTGACTCTGG | 152bp | ||
| GGCTGGCAAGTCGTTCTCG | |||
| CACCCTTCGTGAGACCTTTG | 141bp | ||
| AATATCCCTTTCCCACGTGAC | |||
| ATTCTGTGCGGCCTCTTTAC | 185bp | ||
| ATCGGTCGTTCTTCAGATGG | |||
| GGTGTTCCTGGTGGCACTCT | 114bp | ||
| AGCTCCGTCTCCTCGTTCCT | |||
| CTCAGCCATCTCCTTCTTG | 114bp | ||
| TGTTCTCCTCGTTCTTCAC | |||
| CCACGAGACCACCTACAAC | 142bp | ||
| AGCGAGGGCAGTGATTTC |
Fig. 1Total haemocyte count (THC) (A) in hemolymph, phagocytic activity (B), antibacterial activity (C) and phenoloxidase (PO) activity (D) in plasma of L. vannamei fed YPS diets. Data are means ± SD. (n = 3). Bars with different letters represent significant differences (P < 0.05, Tukey's test) among the control and YPS groups.
Fig. 2The immune related genes expression in the hemocytes of L. vannamei fed YPS for 28 days (A: Toll; B: Imd; C: Dorsal; D: Relish; E: Pen; F: Cru; G: ALF; H: TNF-α). Data are means ± SD. (n = 3). Bars with different letters represent significant differences (P < 0.05, Tukey's test) among the control and YPS groups.
Fig. 3The immune related genes expression in the intestine of L. vannamei fed YPS for 28 days (A: Toll; B: Imd; C: Dorsal; D: Relish; E: Pen; F: Cru; G: ALF; H: TNF-α). Data are means ± SD. (n = 3). Bars with different letters represent significant differences (P < 0.05, Tukey's test) among the control and YPS groups.
Diversity indices of intestine microbiota used in this study.
| Sample name | Observed species | Shannon | Simpson | Chao1 | ACE | Good's coverage |
|---|---|---|---|---|---|---|
| Control | 374.667 ± 23.029a | 5.567 ± 0.331a | 0.935 ± 0.016a | 425.141 ± 64.704a | 401.702 ± 22.087a | 0.999 ± 0.001a |
| YPS1 | 256.667 ± 5.033b | 5.004 ± 0.226ab | 0.946 ± 0.013a | 309.929 ± 19.580b | 308.180 ± 12.942b | 0.998 ± 0.001a |
| YPS2 | 211.667 ± 17.898c | 4.209 ± 0.077c | 0.887 ± 0.003b | 262.521 ± 30.701b | 266.585 ± 32.054bc | 0.999 ± 0.001a |
| YPS3 | 195.667 ± 5.508c | 4.475 ± 0.152bc | 0.920 ± 0.015a | 237.509 ± 9.744b | 245.800 ± 9.743c | 0.999 ± 0.000a |
Data are presented as mean ± SD. Data indicated with different letters were significantly different (P < 0.05) among treatments.
Fig. 4Relative abundances of the dominant bacterial phyla (A) and genus (B) in L. vannamei from different YPS diets treatments.
Fig. 5Analysis of intestinal microbiota structure of L. vannamei from different YPS diets treatments (A: Venn diagram of shared and specific microbial communities at OTUs among four groups; B: Nonmetric Multidimensional scaling (NMDS) analysis among microbial communities of 12 samples; C: UPGMA clustering based on four groups from the gut samples).
Fig. 6Analysis of Predicted functions in KEGG level3 of intestinal microbiota in L. vannamei from different YPS diets treatments. Data indicated with different letters were significantly different (P < 0.05) among treatments.
Fig. 7The relative abundance of candidate genes associated with short-chain fatty acid metabolism of intestinal microbiota. Data indicated with different letters were significantly different (P < 0.05) among treatments.
Fig. 8The cumulative mortality curves of L. vannamei fed with YPS diets in pathogen challenge experiments. Differences in cumulative mortality levels between treatments were analyzed by Kaplan-Meier plot log-rank X2 test.
Effects of diets containing YPS on growth performance of L. vannamei after 28 days of feeding.
| Index | Treatment | |||
|---|---|---|---|---|
| Control | YPS1 | YPS2 | YPS3 | |
| SR% | 91.11 ± 3.42a | 92.78 ± 2.83a | 94.44 ± 0.79a | 95.00 ± 3.60a |
| Initial weight/g | 3.04 ± 0.33a | 3.04 ± 0.33a | 3.04 ± 0.33a | 3.04 ± 0.33a |
| Final weight/g | 5.04 ± 0.22a | 5.34 ± 0.27a | 5.50 ± 0.17a | 5.70 ± 0.45a |
| WG% | 77.94 ± 7.17a | 75.74 ± 8.74a | 81.01 ± 5.61a | 87.06 ± 14.97a |
| SGR%/d | 2.06 ± 0.12a | 2.01 ± 0.14a | 2.12 ± 0.09a | 2.24 ± 0.24a |
Data are presented as mean ± SD. Data indicated with different letters were significantly different (P < 0.05) among treatments.